Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (376) 376
Patent (71) 71
Book Chapter (10) 10
Conference Proceeding (4) 4
Dissertation (4) 4
Book Review (2) 2
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (170) 170
life sciences & biomedicine (153) 153
humans (121) 121
oncology (57) 57
female (53) 53
human necessities (52) 52
hygiene (50) 50
medical or veterinary science (50) 50
preparations for medical, dental, or toilet purposes (50) 50
animals (48) 48
middle aged (47) 47
male (46) 46
hematology (39) 39
adult (38) 38
biological and medical sciences (38) 38
aged (35) 35
medical sciences (33) 33
abridged index medicus (29) 29
chemistry (29) 29
mice (29) 29
metallurgy (24) 24
specific therapeutic activity of chemical compounds ormedicinal preparations (24) 24
cancer (23) 23
surgery (23) 23
treatment outcome (23) 23
aged, 80 and over (20) 20
hemic and lymphatic diseases (20) 20
analysis (19) 19
tumors (19) 19
cell line, tumor (18) 18
lymphoma (18) 18
organic chemistry (18) 18
proteins (18) 18
hematologic and hematopoietic diseases (17) 17
mice, scid (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (16) 16
cell biology (15) 15
care and treatment (14) 14
heating (14) 14
immunology (14) 14
apoptosis (13) 13
blasting (13) 13
combustion engines (13) 13
health aspects (13) 13
hot-gas or combustion-product engine plants (13) 13
lighting (13) 13
mechanical engineering (13) 13
microbiology (13) 13
weapons (13) 13
antineoplastic agents - pharmacology (12) 12
antineoplastic agents - therapeutic use (12) 12
biochemistry (12) 12
controlling combustion engines (12) 12
immunohistochemistry (12) 12
research (12) 12
retrospective studies (12) 12
social sciences (12) 12
sociology (12) 12
gastroenterology & hepatology (11) 11
gene expression (11) 11
patients (11) 11
prognosis (11) 11
rituximab (11) 11
beer (10) 10
biochemistry & molecular biology (10) 10
disease models, animal (10) 10
emergency medicine (10) 10
enzymology (10) 10
heterocyclic compounds (10) 10
mantle cell lymphoma (10) 10
medicine, research & experimental (10) 10
mutation or genetic engineering (10) 10
pathology (10) 10
peptides (10) 10
protein-arginine n-methyltransferases - metabolism (10) 10
research & experimental medicine (10) 10
research article (10) 10
specific use of cosmetics or similar toiletpreparations (10) 10
spirits (10) 10
vinegar (10) 10
wine (10) 10
antineoplastic agents (9) 9
cell cycle (9) 9
disease-free survival (9) 9
ebv (9) 9
epstein-barr virus (9) 9
epstein-barr virus infections - complications (9) 9
exact sciences and technology (9) 9
killer cells, natural - immunology (9) 9
lymphoma, mantle-cell - drug therapy (9) 9
protein-arginine n-methyltransferases - genetics (9) 9
reverse transcriptase polymerase chain reaction (9) 9
review (9) 9
technology (9) 9
antineoplastic agents - administration & dosage (8) 8
diagnosis (8) 8
epstein-barr virus infections - immunology (8) 8
hematology, oncology and palliative medicine (8) 8
lymphocytes (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Targeting PI3‐kinase (PI3K), AKT and mTOR axis in lymphoma
by Blachly, James S and Baiocchi, Robert A
British journal of haematology, ISSN 0007-1048, 10/2014, Volume 167, Issue 1, pp. 19 - 32
mTOR | targeted‐therapy | AKT | PI3K | lymphoma | Targeted-therapy | Lymphoma | MTOR | Life Sciences & Biomedicine | Hematology | Science & Technology | TOR Serine-Threonine Kinases - metabolism | Humans | Treatment Outcome | Antineoplastic Agents - therapeutic use | Phosphatidylinositol 3-Kinases - metabolism | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Lymphoma - metabolism | TOR Serine-Threonine Kinases - antagonists & inhibitors | Lymphoma - drug therapy | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Non-Hodgkin - metabolism | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Lymphoma, Non-Hodgkin - drug therapy | Lymphomas | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions
by McClain, Kenneth L and Picarsic, Jennifer and Chakraborty, Rikhia and Zinn, Daniel and Lin, Howard and Abhyankar, Harshal and Scull, Brooks and Shih, Albert and Lim, Karen Phaik Har and Eckstein, Olive and Lubega, Joseph and Peters, Tricia L and Olea, Walter and Burke, Thomas and Ahmed, Nabil and Hicks, M. John and Tran, Brandon and Jones, Jeremy and Dauser, Robert and Jeng, Michael and Baiocchi, Robert and Schiff, Deborah and Goldman, Stanton and Heym, Kenneth M and Wilson, Harry and Carcamo, Benjamin and Kumar, Ashish and Rodriguez‐Galindo, Carlos and Whipple, Nicholas S and Campbell, Patrick and Murdoch, Geoffrey and Kofler, Julia and Heales, Simon and Malone, Marian and Woltjer, Randy and Quinn, Joseph F and Orchard, Paul and Kruer, Michael C and Jaffe, Ronald and Manz, Markus G and Lira, Sergio A and Parsons, D. Williams and Merad, Miriam and Man, Tsz‐Kwong and Allen, Carl E
Cancer, ISSN 0008-543X, 06/2018, Volume 124, Issue 12, pp. 2607 - 2620
neurodegeneration | CNS neoplasms | BRAF‐V600E | Langerhans cell histiocytosis | osteopontin | BRAF-V600E | Life Sciences & Biomedicine | Oncology | Science & Technology | Brain | Therapy | Pathogenesis | Brain tumors | Central nervous system | Cerebrospinal fluid | CD14 antigen | Metastases | Proteins | Biomedical materials | Neurodegeneration | Etiology | Demyelination | Precursors | Biocompatibility | Lesions | Deoxyribonucleic acid--DNA | Phenotypes | Blood cells | Osteopontin | MAP kinase | Histiocytosis | Patients | Hemopoiesis | CD163 antigen | Monocytes | Inhibitors | Biopsy | Biomarkers | Infiltration | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Driving toward targeted therapy for LCH
by Baiocchi, Robert A
Blood, ISSN 0006-4971, 2014, Volume 124, Issue 10, pp. 1546 - 1548
Life Sciences & Biomedicine | Hematology | Science & Technology | MAP Kinase Kinase 1 - genetics | Female | Male | Proto-Oncogene Proteins B-raf - genetics | Histiocytosis, Langerhans-Cell - genetics | Humans | Index Medicus | Abridged Index Medicus | Inside
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Complete and durable responses in primary central nervous system posttransplant lymphoproliferative disorder with zidovudine, ganciclovir, rituximab, and dexamethasone
by Dugan, James P and Haverkos, Bradley M and Villagomez, Lynda and Martin, Ludmila K and Lustberg, Mark and Patton, John and Martin, Marisa and Huang, Ying and Nuovo, Gerard and Yan, Fengting and Cavaliere, Robert and Fingeroth, Joyce and Kenney, Shannon C and Ambinder, Richard F and Lozanski, Gerard and Porcu, Pierluigi and Caligiuri, Michael A and Baiocchi, Robert A
Clinical cancer research, ISSN 1078-0432, 07/2018, Volume 24, Issue 14, pp. 3273 - 3281
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Tomography, X-Ray Computed | Zidovudine - administration & dosage | Adult | Female | Lymphoproliferative Disorders - etiology | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Rituximab - administration & dosage | Central Nervous System Diseases - etiology | Lymphoproliferative Disorders - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Biopsy | Organ Transplantation - adverse effects | Central Nervous System Diseases - drug therapy | Epstein-Barr Virus Infections - complications | Lymphoproliferative Disorders - drug therapy | Organ Transplantation - methods | Aged | Central Nervous System Diseases - diagnosis | Ganciclovir - administration & dosage | Flow cytometry | Therapy | Sensitivity analysis | Intravenous administration | Dexamethasone | Central nervous system | Rituximab | Viruses | Nervous system | Transplantation | Kinases | Gene expression | Patients | Proteins | Sensitivity | Ganciclovir | Transfection | Lymphocytes | Medical prognosis | Protein expression | Zidovudine | Posttransplant lymphoproliferative disorders | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text PU.1 and epigenetic signals modulate 1,25‐dihydroxyvitamin D3 and C/EBPα regulation of the human cathelicidin antimicrobial peptide gene in lung epithelial cells
by Wei, Ran and Dhawan, Puneet and Baiocchi, Robert A and Kim, Ki‐Yoon and Christakos, Sylvia
Journal of cellular physiology, ISSN 0021-9541, 07/2019, Volume 234, Issue 7, pp. 10345 - 10359
25‐dihydroxyvitamin D3 | 1 | Brahma‐related gene 1 | cathelicidin | protein arginine methyltransferase 5 | PU.1 | histone acetylation | Regulations | Histone deacetylase | BRG1 protein | Sucrose | Peptides | Epithelial cells | Protein arginine methyltransferase | Calcitriol | CCAAT/enhancer-binding protein | Gene expression | Antiinfectives and antibacterials | Bactericidal activity | Chromatin remodeling | Respiratory tract | Proteins | PU.1 protein | Dihydroxyvitamin D3 | Arginine | Vitamin D | Lungs | Antimicrobial peptides | Acetylation | Methylation | Sugars | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
by Baiocchi, Robert A and Byrd, John C and Pal, Sharmistha and Grever, Michael R and Sif, Saïd and Jacob, Samson T
The EMBO journal, ISSN 0261-4189, 08/2007, Volume 26, Issue 15, pp. 3558 - 3569
H3R8 and H4R3 methylation | miR‐92b and miR‐96 | PRMT5 | mantle cell lymphoma | ST7 | miR-92b and miR-96 | Mantle cell lymphoma | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | DNA Methylation | Protein Biosynthesis | Chromatin Immunoprecipitation | Humans | RNA, Messenger - genetics | Gene Silencing | Cell Line, Tumor | Protein-Arginine N-Methyltransferases - genetics | Histones - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Lymphoma, Mantle-Cell - genetics | Cellular biology | Molecular biology | Gene expression | Lymphoma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text PRMT5 is upregulated in HTLV-1-mediated T-Cell transformation and selective inhibition alters viral gene expression and infected cell survival
by Panfil, Amanda R and Al-Saleem, Jacob and Howard, Cory M and Mates, Jessica M and Kwiek, Jesse J and Baiocchi, Robert A and Green, Patrick L
Viruses, ISSN 1999-4915, 12/2015, Volume 8, Issue 1, pp. 7 - 7
HBZ | PRMT5 | Transformation | HTLV-1 | Tax | P30 | ATLL | Lymphoma | Life Sciences & Biomedicine | Science & Technology | Virology | Up-Regulation | Cell Survival | Leukemia-Lymphoma, Adult T-Cell - genetics | Humans | Gene Products, tax - genetics | Leukemia-Lymphoma, Adult T-Cell - physiopathology | Human T-lymphotropic virus 1 - physiology | Protein-Arginine N-Methyltransferases - metabolism | Gene Products, tax - metabolism | Gene Expression Regulation, Viral | Human T-lymphotropic virus 1 - genetics | Protein-Arginine N-Methyltransferases - genetics | Cell Transformation, Viral | Leukemia-Lymphoma, Adult T-Cell - enzymology | Index Medicus | lymphoma | transformation | p30
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling
by Chung, Jihyun and Karkhanis, Vrajesh and Baiocchi, Robert A and Sif, Saïd
The Journal of biological chemistry, ISSN 0021-9258, 05/2019, Volume 294, Issue 19, pp. 7692 - 7710
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Signal Transduction | Cell Survival | Gene Expression Regulation, Neoplastic | Glycogen Synthase Kinase 3 beta - genetics | Lymphoma - genetics | Glycogen Synthase Kinase 3 beta - metabolism | beta Catenin - metabolism | Proto-Oncogene Proteins c-akt - genetics | beta Catenin - genetics | Protein-Arginine N-Methyltransferases - metabolism | Lymphoma - metabolism | Animals | Cell Line, Tumor | Lymphoma - pathology | Mice | Protein-Arginine N-Methyltransferases - genetics | Proto-Oncogene Proteins c-akt - metabolism | Wnt Signaling Pathway | Index Medicus | protein kinase B (AKT) | glycogen synthase kinase 3β | lymphoma | Akt PKB | Gene Regulation | protein arginine methyltransferase 5 (PRMT5) | Wnt signaling | non-Hodgkin's lymphoma | β-catenin signaling | protein arginine N-methyltransferase 5 (PRMT5) | histone | WNT | WNT antagonists
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
by Ramos, Juan C and Sparano, Joseph A and Chadburn, Amy and Reid, Erin G and Ambinder, Richard F and Siegel, Eric R and Moore, Page C and Rubinstein, Paul G and Durand, Christine M and Cesarman, Ethel and Aboulafia, David and Baiocchi, Robert and Ratner, Lee and Kaplan, Lawrence and Capoferri, Adam A and Lee, Jeannette Y and Mitsuyasu, Ronald and Noy, Ariela and AIDS Malignancy Consortium
Blood, ISSN 0006-4971, 09/2020, Volume 136, Issue 11, pp. 1284 - 1297
Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
by Shindiapina, Polina and Ahmed, Elshafa H and Mozhenkova, Anna and Abebe, Tamrat and Baiocchi, Robert A
Frontiers in oncology, ISSN 2234-943X, 09/2020, Volume 10, pp. 1723 - 1723
Life Sciences & Biomedicine | Oncology | Science & Technology | Infection | HIV patients | Non-Hodgkin's lymphomas | HIV (Viruses) | Health aspects | Epstein-Barr virus | immunodeficiency | Immunology | lymphoproliferative disease | HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights